STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).

Providing Solutions for the Home & Alternate Site Infusion Community
NHIA is the leading organization providing education, information, advocacy, and resources for the nation’s home and alternate site infusion provider community and the manufacturers, suppliers, and service companies that support the field.
Previous
Next
NHIA is the leading organization providing education, information, advocacy, and resources for the nation’s home and alternate site infusion provider community and the manufacturers, suppliers, and service companies that support the field.
Previous
Next

NHIF Benchmarking Program

Be part of NHIF’s benchmarking program to collect industry-wide, standardized data to establish a national reference point for performance and clinical metrics.

 

Get Involved!
NHIA Committee Opportunities

NHIA committees bring together the thought leaders and innovators in home and alternate site infusion therapy and complement and support staff efforts to promote and achieve the association’s mission and vision.

Modernizing the Home Infusion Coding System

NHIA is seeking member review and comment on a proposal to request modifications to the home infusion Healthcare Common Procedure Coding System (HCPCS) codes (S-codes).

Latest News

Considerations for Addressing ExactaMix Automated Compounding Device (ACD) Valve Set Supply Disruption

On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.

Read More »

NHIA Releases Comments on California Senate Bill 958

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »

National Home Infusion Foundation Launches Infusion Journal

The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

Read More »

NHIA Submits Comments on DIR Proposed Rule

NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).

Read More »

We Need Your Support

NHIA is dedicating extra resources to pursue legislation to allow home infusion providers to serve Medicare beneficiaries during the public health emergency related to COVID-19.